Kyntra Bio Inc (KYNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 36,997 | 47,872 | 117,975 | 23,367 | 33,609 |
| Marketable Securities | 50,240 | 41,106 | N/A | N/A | N/A |
| Receivables | 5,040 | 216 | 121 | 136 | 147 |
| Inventories | 3,384 | 3,743 | 3,864 | 3,863 | 3,155 |
| Other current assets | 0 | 0 | 0 | 132,650 | 108,292 |
| TOTAL | $101,355 | $99,073 | $133,423 | $162,322 | $148,529 |
| Non-Current Assets | |||||
| Investments And Advances | 8,026 | 20,160 | 3,035 | 0 | 0 |
| Other Non-Current Assets | 248 | 361 | 556 | 15,733 | 16,684 |
| TOTAL | $8,274 | $20,521 | $3,591 | $15,733 | $16,684 |
| Total Assets | $109,629 | $119,594 | $137,014 | $178,055 | $165,213 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 73,733 | N/A |
| Accounts payable and accrued liabilities | 5,094 | 3,745 | 5,093 | 10,477 | 7,282 |
| Accrued Expenses | 17,340 | 20,183 | 25,776 | 35,916 | 35,324 |
| Other current liabilities | N/A | N/A | N/A | 8,458 | 8,275 |
| TOTAL | $28,114 | $29,242 | $35,973 | $155,895 | $73,390 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 73,419 |
| Deferred Revenues | 5,680 | 5,314 | 5,104 | 27,311 | 22,509 |
| Other Non-Current Liabilities | 108,210 | 107,102 | 104,463 | 102,446 | 99,466 |
| TOTAL | $112,285 | $107,357 | $105,036 | $224,670 | $288,232 |
| Total Liabilities | $140,399 | $136,599 | $141,009 | $380,565 | $361,622 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,048 | 4,047 | 4,045 | 4,044 | 4,042 |
| Common Shares | 40 | 1,012 | 1,011 | 1,011 | 1,010 |
| Retained earnings | -1,721,245 | -1,706,047 | -1,691,827 | -1,892,463 | -1,884,860 |
| Other shareholders' equity | 11,140 | 10,851 | 10,822 | 15,693 | 16,053 |
| TOTAL | $-30,770 | $-17,005 | $-3,995 | $-202,510 | $-196,409 |
| Total Liabilities And Equity | $109,629 | $119,594 | $137,014 | $178,055 | $165,213 |